# BeOne Medicines Ltd.

> BeOne Medicines Ltd. is a VC fund in Klein-basel. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Klein-basel, Switzerland
- Total investments: 1
- Last investment: Apr 2026
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/beonemedicines
- Website: https://beonemedicines.com

BeOne Medicines Ltd. is a VC fund in Klein-basel. BeOne Medicines is a global oncology biotechnology company focused on discovering, developing, manufacturing, and commercializing cancer medicines. It offers approved therapies such as BRUKINSA (zanubrutinib) for hematologic malignancies and TEVIMBRA (tislelizumab) for solid tumors, alongside a broad pipeline of investigational agents includingsonrotoclax, BGB-16673, and antibody-drug conjugates. BeOne conducts late-stage clinical trials across blood and solid cancers, operates biologics manufacturing facilities, and runs patient support, expanded access, and clinical trial programs. The company engages in global partnerships and access initiatives to expand availability of its oncology treatments.

## Contacts

5 contacts available for BeOne Medicines Ltd.. Shizune tracks 2 team members at BeOne Medicines Ltd.. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/beone-medicines-ltd?utm_source=investor_profile

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Joao Barreiro | Chief Privacy & Data Ethics Officer | 0 | https://shizune.co/investors/profile/joao-torres-barreiro |
| Niyoshi Patel | Senior Director, Business Development & Investments | 0 | https://shizune.co/investors/profile/niyoshi-p-patel |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Terremoto Biosciences | Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines. | $108M | Series C | Apr 15, 2026 |  |

1 of 1 investments shown.

## Co-investors
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund, 2 deals together
- [Third Rock Ventures](https://shizune.co/investors/profile/third-rock-ventures) — VC Fund, 2 deals together
- [Cormorant Asset Management](https://shizune.co/investors/profile/cormorant-asset-management) — VC Fund, 1 deal together
- [Deep Track Capital](https://shizune.co/investors/profile/deep-track-capital) — VC Fund, 1 deal together
- [Novo Holdings](https://shizune.co/investors/profile/novo-a-s) — VC Fund, 1 deal together
- [OUP (Osage University Partners)](https://shizune.co/investors/profile/osage-university-partners) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### How do I contact BeOne Medicines Ltd.?

Public channels for BeOne Medicines Ltd. include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at BeOne Medicines Ltd.?

The team at BeOne Medicines Ltd. includes Joao Barreiro (Chief Privacy & Data Ethics Officer) and Niyoshi Patel (Senior Director, Business Development & Investments). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co